Suppr超能文献

探讨橙皮苷治疗伊立替康引起的腹泻的作用及潜在机制:网络药理学、分子对接和实验验证。

Exploring the Effects and Potential Mechanisms of Hesperidin for the Treatment of CPT-11-Induced Diarrhea: Network Pharmacology, Molecular Docking, and Experimental Validation.

机构信息

School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

出版信息

Int J Mol Sci. 2024 Aug 28;25(17):9309. doi: 10.3390/ijms25179309.

Abstract

Chemotherapy-induced diarrhea (CID) is a potentially serious side effect that often occurs during anticancer therapy and is caused by the toxic effects of chemotherapeutic drugs on the gastrointestinal tract, resulting in increased frequency of bowel movements and fluid contents. Among these agents, irinotecan (CPT-11) is most commonly associated with CID. Hesperidin (HPD), a flavonoid glycoside found predominantly in citrus fruits, has anti-oxidation properties and anti-inflammation properties that may benefit CID management. Nevertheless, its potential mechanism is still uncertain. In this study, we firstly evaluated the pharmacodynamics of HPD for the treatment of CID in a mouse model, then used network pharmacology and molecular docking methods to excavate the mechanism of HPD in relieving CID, and finally further proved the predicted mechanism through molecular biology experiments. The results demonstrate that HPD significantly alleviated diarrhea, weight loss, colonic pathological damage, oxidative stress, and inflammation in CID mice. In addition, 74 potential targets for HPD intervention in CID were verified by network pharmacology, with the top 10 key targets being AKT1, CASP3, ALB, EGFR, HSP90AA1, MMP9, ESR1, ANXA5, PPARG, and IGF1. The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that the PI3K-Akt pathway, FoxO pathway, MAPK pathway, TNF pathway, and Ras pathway were most relevant to the HPD potential treatment of CID genes. The molecular docking results showed that HPD had good binding to seven apoptosis-related targets, including AKT1, ANXA5, CASP3, HSP90AA1, IGF1, MMP9, and PPARG. Moreover, we verified apoptosis by TdT-mediated dUTP nick-end labeling (TUNEL) staining and immunohistochemistry, and the hypothesis about the proteins above was further verified by Western blotting in vivo experiments. Overall, this study elucidates the potential and underlying mechanisms of HPD in alleviating CID.

摘要

化疗引起的腹泻(CID)是一种潜在的严重副作用,通常在癌症治疗过程中发生,是化疗药物对胃肠道的毒性作用引起的,导致排便次数和液体含量增加。在这些药物中,伊立替康(CPT-11)与 CID 最相关。橙皮苷(HPD)是一种主要存在于柑橘类水果中的类黄酮糖苷,具有抗氧化和抗炎特性,可能有益于 CID 的管理。然而,其潜在机制仍不确定。在这项研究中,我们首先在小鼠模型中评估了 HPD 治疗 CID 的药效学,然后使用网络药理学和分子对接方法挖掘 HPD 缓解 CID 的机制,并通过分子生物学实验进一步证实了预测的机制。结果表明,HPD 可显著缓解 CID 小鼠的腹泻、体重减轻、结肠病理损伤、氧化应激和炎症。此外,通过网络药理学验证了 HPD 干预 CID 的 74 个潜在靶点,前 10 个关键靶点为 AKT1、CASP3、ALB、EGFR、HSP90AA1、MMP9、ESR1、ANXA5、PPARG 和 IGF1。京都基因与基因组百科全书(KEGG)富集分析表明,PI3K-Akt 通路、FoxO 通路、MAPK 通路、TNF 通路和 Ras 通路与 HPD 治疗 CID 基因的潜在相关性最为密切。分子对接结果表明,HPD 与包括 AKT1、ANXA5、CASP3、HSP90AA1、IGF1、MMP9 和 PPARG 在内的 7 个凋亡相关靶点具有良好的结合能力。此外,我们通过 TdT 介导的 dUTP 缺口末端标记(TUNEL)染色和免疫组织化学验证了凋亡,体内实验进一步通过 Western blot 验证了上述蛋白的假设。总的来说,本研究阐明了 HPD 缓解 CID 的潜力和潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2e/11394706/190d5f62578e/ijms-25-09309-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验